Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
12/28/2006 | US20060292598 Nucleotide sequences coding mitogenic racemase for use diagnostic probe in detection and prevention of parasite infection; immunotherapy |
12/28/2006 | US20060292596 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens |
12/28/2006 | US20060292580 Cleavage of nucleic acids |
12/28/2006 | US20060292578 Nucleotide sequences coding thermus filiformis heat resistant transferase with reduced exonuclease activity; for use in DNA sequencing, nucleic acid amplification, cDNA and nucleic synthesis |
12/28/2006 | US20060292566 Method for optimising gene expressing using synonymous codon optimisation |
12/28/2006 | US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception |
12/28/2006 | US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
12/28/2006 | US20060292168 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
12/28/2006 | US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
12/28/2006 | US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin |
12/28/2006 | US20060292139 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
12/28/2006 | US20060292133 Use of lactobacillus salivarius |
12/28/2006 | US20060292130 2-O sulfatase nucleic acid compositions |
12/28/2006 | US20060292118 Hollow nanoparticles of protein and drug using the same |
12/28/2006 | DE102005029170A1 System zur Genexpression in Hefen der Gattung Sporidiobolus System for gene expression in yeast of the genus Sporidiobolus |
12/28/2006 | DE102005029148A1 Vorrichtung zur Luftaufbereitung sowie Oberflächenbehandlungsanlage mit derselben Apparatus for air purification and surface treatment plant with the same |
12/28/2006 | DE102005027557A1 Method for increased expression of G-protein coupled receptor, comprises coupling at least a co-experimented chaperon of heat shock protein to the G-protein |
12/28/2006 | CA2613257A1 A novel biological substance nesfatin and its related substances and uses thereof |
12/28/2006 | CA2611877A1 Synthetic gene control region |
12/28/2006 | CA2611513A1 Improved amino acid and metabolite biosynthesis |
12/28/2006 | CA2607911A1 Lactobacillus strains for protecting the skin against pathogenic microorganisms |
12/27/2006 | EP1736545A2 Soluble zcytor 11 cytokine receptors |
12/27/2006 | EP1736544A1 Gm1 PROMOTER AND USE THEREOF |
12/27/2006 | EP1736541A1 Novel galectin 9 modification protein and use thereof |
12/27/2006 | EP1736537A1 Methods and means for protecting the skin against pathogenic microorganisms |
12/27/2006 | EP1735455A2 Methods for producing hyaluronic acid in a bacillus cell |
12/27/2006 | EP1735451A1 Mutated prokaryotic cells with high secretion-levels |
12/27/2006 | EP1735436A2 A NOVEL MODULAR TYPE II RESTRICTION ENDONUCLEASE, CspCI, AND THE USE OF MODULAR ENDONUCLEASES FOR GENERATING ENDONUCLEASES WITH NEW SPECIFICITIES |
12/27/2006 | EP1551992B1 Screening molecules with anti-prion activity: kits, methods and screened molecules |
12/27/2006 | EP1507863B1 Plasmid stabilisation in vivo |
12/27/2006 | EP1432789B1 Mutated lactococcus strain |
12/27/2006 | EP1354047B1 Methods for screening compounds that modulate lipid metabolism |
12/27/2006 | EP1291431B1 Endoglucanase nce5 |
12/27/2006 | EP1282687B1 Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same |
12/27/2006 | EP1231266B1 Arabidopsis-origin gdp-4-keto-6-deoxy-d-mannose-3,5-epimerase-4-reductase gene |
12/27/2006 | EP1210449B1 Methods for the detection, analysis and isolation of nascent proteins |
12/27/2006 | EP1185618B1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
12/27/2006 | EP1183362B1 Il-1 eta dna and polypeptides |
12/27/2006 | EP1163344B1 Hyphal growth in fungi |
12/27/2006 | EP1123386B1 Method for producing chiral carboxylic acids from nitriles with the assistance of a nitrilase or microorganisms which contain a gene for the nitrilase |
12/27/2006 | EP1117798B1 Fungal transcriptional activator prtt from aspergillus niger, useful in methods for producing polypeptides |
12/27/2006 | EP1105505B1 Compound and method for the prevention and/or the treatment of allergy |
12/27/2006 | EP1034273B1 Histamine and serotonin binding molecules |
12/27/2006 | EP1011697B1 Targeted system for removing tumor cells from cell populations |
12/27/2006 | EP1005527B1 Highly transformable bacterial cells and methods for producing the same |
12/27/2006 | CN1886516A Method to produce succinic acid from raw hydrolysates |
12/27/2006 | CN1886508A Sesquiterpene synthases from patchouli |
12/27/2006 | CN1886506A Protein expressed in nk cell |
12/27/2006 | CN1886505A DNA participating in hydroxylation of macrolide compound |
12/27/2006 | CN1886504A Gene amplification method |
12/27/2006 | CN1886502A Strain of rhodococcus rhodochrous ncimb 41164 and its use asproducer of nitrile hydratase |
12/27/2006 | CN1886501A Process for preparing unsaturated amides and carboxylic acids |
12/27/2006 | CN1886053A Liquid leaven composition |
12/27/2006 | CN1884567A L-glutamine ferment medium preparation method |
12/27/2006 | CN1884559A Goosegrass bipolaris crude toxin extraction process and formulation |
12/27/2006 | CN1884549A SjADA coding gene, its construction method and its in vitro fusion expression product and expression method |
12/27/2006 | CN1884533A Vitreoscilla hemoglobin gene and its uses |
12/27/2006 | CN1884527A Method for preparing protein using endogenetic angiogenesis inhibitive factor Arresten gene |
12/27/2006 | CN1884511A Method for fixing acidophilic bacteria |
12/27/2006 | CN1884509A Preparation method of hybrid hydrolase formulation for promoting methane yield from fermentation |
12/27/2006 | CN1884508A Mutant xylose isomerase and its gene |
12/27/2006 | CN1884506A Composite microorganism beta-dextranase and beta-glucosaccharase production method |
12/27/2006 | CN1884502A Candida parapsilosis CCTCC M203011 (S)- carbonyl reduction enzyme gene sequence and amino acid composition |
12/27/2006 | CN1884501A Glutamine synthetase and its dedicated expression engineered bacteria and uses |
12/27/2006 | CN1884490A Agrobacterium rhizogenes mediated aconitum coreanum and its obtaining method |
12/27/2006 | CN1884485A Method for obtaining spiramycin single component strain |
12/27/2006 | CN1884484A Succinic acid-producing strain and its screening method and uses |
12/27/2006 | CN1884483A Marine bacteria strain for producing prodigiosin and the method for producing prodigiosin |
12/27/2006 | CN1884482A Aerogenic enteric bacilli secreting alga-dissolving substance and its uses in myxophyceae algal tufa |
12/27/2006 | CN1884481A Biological control bacillus subtilis for crop bacterial wilt |
12/27/2006 | CN1884480A Method for screening allotrophic nitrobacteria |
12/27/2006 | CN1884479A Anti AIDS 1 type virus compound preparation method |
12/27/2006 | CN1884478A Aspergillus niger variant and its fermentation process in solid medium |
12/27/2006 | CN1884477A Fusarium solani mutant for producing chitosan enzyme and its uses in preparing chitosan |
12/27/2006 | CN1884476A Aspergillus oryzae bacteria and its application |
12/27/2006 | CN1884468A Process for preparing northern Chinese caterpillar fungus health wine |
12/27/2006 | CN1884221A Method for producing bioorganic fertilizer and bioorganic fertilizer therefrom |
12/27/2006 | CN1883517A Preparation of fungi extract and application thereof in resisting HIV |
12/27/2006 | CN1883248A Method for improving quality of Ganoderma lucidium spore |
12/27/2006 | CN1292068C Enhanced expression of proteolytic enzymes in koji mold |
12/27/2006 | CN1292065C Method of concentrating gene |
12/27/2006 | CN1292064C Microorganism strain and method for converting cephalosporin C into deacetylate cephalosporin C by using same |
12/27/2006 | CN1291990C Biocidal compounds and their preparation |
12/27/2006 | CA2549275A1 Neoplasia-specific splice variants and methods |
12/26/2006 | US7154026 Arabidopsis lyases for modulating starch and polysaccharide concentration in plant cells and organs; antisense agents |
12/26/2006 | US7153952 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
12/26/2006 | US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
12/26/2006 | US7153945 Peptide, novel adsorbent, adsorption unit and adsorption method |
12/26/2006 | US7153942 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy |
12/26/2006 | US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
12/26/2006 | US7153935 Tumor suppressor gene |
12/26/2006 | US7153932 Immunotoxins comprising ribosome-inactivating proteins |
12/26/2006 | US7153818 Amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
12/26/2006 | US7153683 Present invention relates generally to compositions and methods for modulating activity of MAP/ERK kinase MEK3 and/or other MEK family members; is particularly related to polypeptide variants of TAO proteins |
12/26/2006 | US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof |
12/26/2006 | US7153677 Isolated, recombinantly produced, enzymatically active hyaluronan synthase; a single protein that is a dual-action catalyst that utilizes UDP-GlcA and UDP-GlcNAc to synthesize hyaluronic acid |
12/26/2006 | US7153676 purified protein; nucleic acid sequences encoding the transacylases and fragments of the transacylases can be cloned, using standard molecular biology techniques, into vectors to transform host cells |
12/26/2006 | US7153674 Comprises sucrose fructosyltransferases (SST) for fermenting water-soluble, biodegradable polysaccharides for use as detergents, suspension agents, artificial sweeteners and food additives |
12/26/2006 | US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases |
12/26/2006 | US7153668 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disoders |